Smart control lipid-based nanocarriers for fine-tuning gut hormone secretion

Area of Science:

• Gastroenterology and Endocrinology
• Nanotechnology
• Metabolic Disease Research

Background:

• Modulating gastrointestinal hormones is a key strategy for metabolic dysfunction.
• Enteroendocrine cells (EECs) play a crucial role in gut endocrine function.

Purpose of the Study:

• To investigate the potential of lipid nanocarriers to modulate endogenous gastrointestinal hormone release.
• To explore the therapeutic applications of nanotechnology in managing metabolic dysfunction.

Main Methods:

• Utilized mouse and human knock-in/knockout intestinal organoids.
• Formulated lipid nanocarriers using commercial lipid excipients.
• Studied effects in wild-type, dysglycemic, and gut Gcg knockout mice.

Main Results:

• Lipid nanocarriers activated nutrient-sensitive receptors on EECs.
• Demonstrated release of GLP-1, GIP, and PYY from K and L cells.
• Excipient type, formulation, and nanocarrier properties modulated biological effects.

Conclusions:

• Nanotechnology offers a promising, noninvasive therapeutic approach for metabolic dysfunction.
• Modulating multiple endogenous hormones via lipid nanocarriers is feasible.
• This strategy presents a patient-friendly and cost-effective method for hormone modulation.